Showing results (141-150 of 234) with videos related to

Sort By:
Pageof 24
Leukemia & Lymphoma|June 14, 2021
Body mass index and survival of patients with lymphomaDai Chihara, Melissa C Larson, Dennis P Robinson, et al.
The Lancet. Oncology|April 7, 2016
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trialAnas Younes, Jesus G Berdeja, Manish R Patel, et al.
Cancer Science|September 4, 2014
Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry dataYuri Ito, Isao Miyashiro, Hidemi Ito, et al.
Leukemia & Lymphoma|April 5, 2018
Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapyChelsea C Pinnix, Andrew Wirth, Sarah A Milgrom, et al.
Blood|August 3, 2006
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop Kantarjian, Yasuhiro Oki, Guillermo Garcia-Manero, et al.
The Lancet. Oncology|October 29, 2011
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trialAnas Younes, Yasuhiro Oki, R Gregory Bociek, et al.
British Journal of Haematology|April 7, 2017
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcomaPreetesh Jain, Sarah A Milgrom, Keyur P Patel, et al.
The Oncologist|August 16, 2018
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation BurdenWinnie S Liang, Jo-Anne Vergilio, Bodour Salhia, et al.
Leukemia & Lymphoma|March 16, 2013
Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphomaBouthaina S Dabaja, Jack Phan, Osama Mawlawi, et al.
International Journal of Hematology|November 16, 2018
Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphomaSatoshi Yamasaki, Dai Chihara, Sung-Won Kim, et al.
Pageof 24